Cannara Biotech Inc. (LOVE.V)
CAD 0.68
(0.0%)
CAD 0.68
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 41.51 Million CAD | 14.43% |
| 2022 | 36.27 Million CAD | 184.8% |
| 2021 | 12.73 Million CAD | 146.66% |
| 2020 | 5.16 Million CAD | 138.88% |
| 2019 | -13.28 Million CAD | -10560.89% |
| 2018 | 126.97 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 46.01 Million CAD | 10.85% |
| 2024 Q3 | 43.41 Million CAD | -6.27% |
| 2024 Q2 | 46.31 Million CAD | 0.66% |
| 2023 Q1 | 41.44 Million CAD | 14.24% |
| 2023 Q4 | 41.51 Million CAD | 2.46% |
| 2023 FY | 41.51 Million CAD | 14.43% |
| 2023 Q3 | 40.51 Million CAD | 3.3% |
| 2023 Q2 | 39.22 Million CAD | -5.36% |
| 2022 Q2 | 22.96 Million CAD | 33.69% |
| 2022 Q1 | 17.17 Million CAD | 34.86% |
| 2022 FY | 36.27 Million CAD | 184.8% |
| 2022 Q4 | 36.27 Million CAD | 32.35% |
| 2022 Q3 | 27.41 Million CAD | 19.36% |
| 2021 Q4 | 12.73 Million CAD | 16.07% |
| 2021 Q2 | 11.93 Million CAD | 22.84% |
| 2021 FY | 12.73 Million CAD | 146.66% |
| 2021 Q1 | 9.71 Million CAD | 88.1% |
| 2021 Q3 | 10.97 Million CAD | -8.03% |
| 2020 FY | 5.16 Million CAD | 138.88% |
| 2020 Q4 | 5.16 Million CAD | 167.58% |
| 2020 Q3 | 1.92 Million CAD | 234.79% |
| 2020 Q1 | -3.74 Million CAD | 71.83% |
| 2020 Q2 | -1.43 Million CAD | 61.74% |
| 2019 Q4 | -13.28 Million CAD | 24.64% |
| 2019 FY | -13.28 Million CAD | -10560.89% |
| 2019 Q3 | -17.62 Million CAD | 22.25% |
| 2019 Q1 | -34.37 Thousand CAD | 0.0% |
| 2019 Q2 | -22.66 Million CAD | -65849.46% |
| 2018 FY | 126.97 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 4.89 Million CAD | -748.313% |
| CanadaBis Capital Inc. | 4.08 Million CAD | -916.447% |
| Decibel Cannabis Company Inc. | 37.48 Million CAD | -10.751% |
| Delivra Health Brands Inc. | -2.17 Million CAD | 2010.394% |
| Entourage Health Corp. | 150.32 Million CAD | 72.385% |
| Lifeist Wellness Inc. | -188.12 Thousand CAD | 22166.173% |
| Medicure Inc. | -5.82 Million CAD | 812.667% |
| PharmaCielo Ltd. | 18.24 Million CAD | -127.512% |
| Rubicon Organics Inc. | 475.37 Thousand CAD | -8632.713% |
| BioSyent Inc. | -3.68 Million CAD | 1226.546% |
| Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | -109389.308% |